These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6294800

  • 1. Clinical experience with cefotaxime in the treatment of serious bone and joint infections.
    LeFrock JL, Carr BB.
    Rev Infect Dis; 1982; 4 Suppl():S465-71. PubMed ID: 6294800
    [Abstract] [Full Text] [Related]

  • 2. Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime.
    LeFrock J, Mader J, Smith B, Carr B.
    Infection; 1985; 13 Suppl 1():S50-5. PubMed ID: 4055056
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cefmenoxime therapy in bacterial osteomyelitis.
    Sheftel TG, Cierny G, Lefrock JL, Mader JT.
    Am J Med; 1984 Dec 21; 77(6A):17-20. PubMed ID: 6097118
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
    Löffler L, Bauernfeind A, Keyl W, Hoffstedt B, Piergies A, Lenz W.
    Rev Infect Dis; 1986 Dec 21; 8 Suppl 5():S593-8. PubMed ID: 3026009
    [Abstract] [Full Text] [Related]

  • 8. Safety profile and efficacy of cefotaxime for the treatment of hospitalized children.
    Jacobs RF, Darville T, Parks JA, Enderlin G.
    Clin Infect Dis; 1992 Jan 21; 14(1):56-65. PubMed ID: 1571464
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of bone and joint infections utilizing a third-generation cephalosporin with an outpatient drug delivery device. HIAT Study Group.
    Mauceri AA.
    Am J Med; 1994 Aug 15; 97(2A):14-22. PubMed ID: 8059796
    [Abstract] [Full Text] [Related]

  • 13. Cefotaxime: clinical and bacteriologic evaluation.
    Saroglou G, Paniara-Volika O, Sima A, Koltsida K, Rokas S, Kontomichalou P.
    Clin Ther; 1981 Aug 15; 4(3):201-11. PubMed ID: 6272994
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ceftriaxone for the treatment of serious infections.
    Steele RW, Bradsher RW.
    Am J Dis Child; 1983 Nov 15; 137(11):1044-7. PubMed ID: 6314805
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.